Xponance’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-14,093
| Closed | -$1.86M | – | 1552 |
|
|
2025
Q1 | $1.86M | Buy |
14,093
+484
| +4% | +$63.8K | 0.02% | 535 |
|
|
2024
Q4 | $1.14M | Buy |
13,609
+628
| +5% | +$52.5K | 0.01% | 681 |
|
|
2024
Q3 | $950K | Sell |
12,981
-348
| -3% | -$25.5K | 0.01% | 717 |
|
|
2024
Q2 | $913K | Buy |
13,329
+7,671
| +136% | +$525K | 0.01% | 699 |
|
|
2024
Q1 | $392K | Sell |
5,658
-18
| -0.3% | -$1.25K | ﹤0.01% | 1014 |
|
|
2023
Q4 | $407K | Buy |
5,676
+163
| +3% | +$11.7K | ﹤0.01% | 994 |
|
|
2023
Q3 | $287K | Buy |
5,513
+31
| +0.6% | +$1.62K | ﹤0.01% | 1047 |
|
|
2023
Q2 | $347K | Sell |
5,482
-172
| -3% | -$10.9K | ﹤0.01% | 1009 |
|
|
2023
Q1 | $306K | Buy |
5,654
+31
| +0.6% | +$1.68K | ﹤0.01% | 1040 |
|
|
2022
Q4 | $298K | Buy |
5,623
+22
| +0.4% | +$1.16K | ﹤0.01% | 1038 |
|
|
2022
Q3 | $260K | Buy |
5,601
+666
| +13% | +$30.9K | 0.01% | 1035 |
|
|
2022
Q2 | $282K | Buy |
4,935
+1,101
| +29% | +$62.9K | 0.01% | 1028 |
|
|
2022
Q1 | $235K | Buy |
+3,834
| New | +$235K | ﹤0.01% | 1076 |
|